Environmental, Social, and Governance Information Disclosure: Who Discloses Wins?
ABSTRACT As Environmental, Social, and Governance (ESG) Information Disclosure (ESG‐ID) transitions from voluntary to mandatory disclosure, its drivers and impacts have become focal points of discussion. Existing research, however, lacks integration, which, in turn, has led to fragmented theoretical and practical insights.
Siqi Wang +3 more
wiley +1 more source
Optimizing identification of Lyme disease diagnoses in commercial insurance claims data, United States, 2016-2019. [PDF]
Nawrocki CC +4 more
europepmc +1 more source
ABSTRACT The transition to a circular economy (CE) increasingly depends on circular ecosystems: networks of autonomous yet interdependent actors that must coordinate material, information, and value flows to narrow, slow, and close resource loops. This creates a governance problem: Circularity requires orchestration, yet no single actor can impose ...
Felix Carl Schultz +3 more
wiley +1 more source
Meningococcal vaccination disparities in the United States (2010-2021): Findings from the National Immunization Survey-Teen and a commercial insurance database. [PDF]
Herrera-Restrepo O +5 more
europepmc +1 more source
Repair in the Circular Economy: From Fragmented Practices to Strategic Repair Capability
ABSTRACT Repair is central to the circular economy, yet research remains fragmented across product design, consumer behaviour, business models, community initiatives and policy, limiting understanding of how these dimensions interact to enable repair at scale.
Azar MahmoumGonbadi +2 more
wiley +1 more source
Techno‐Economic Assessment of Biomethane and Biohydrogen Production From Victorian Wheat Straw
Techno‐economic assessment of biomethane and biohydrogen production from Victorian wheat straw. Off‐grid renewable photovoltaic energy with a price down to 0.95 ¢/kWh was applied. Both approaches can make positive profits and negative carbon footprints.
Shuanglong Tan +7 more
wiley +1 more source
The Burden of Comorbid Depression and Type 2 Diabetes: An Empirical Study Using Commercial Insurance Data. [PDF]
Ahn S +6 more
europepmc +1 more source
Traditional dosing strategies often rely on a “one‐size‐fits‐all” paradigm, assuming an “average” patient with typical demographic and pharmacological characteristics. In reality, this often overlooks existing between‐patient variability and can lead to suboptimal drug exposure or toxicity. This issue is especially pronounced in pediatric patients, who
Zachary L. Taylor +12 more
wiley +1 more source
Commercial Insurance Coverage Criteria for Autologous Chondrocyte Implantation Poorly Reflect Current Research. [PDF]
Kotlier JL +8 more
europepmc +1 more source

